Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Innovative Transport Ventilator Aids Emergency Care

By HospiMedica International staff writers
Posted on 10 Dec 2009
A new transport ventilator delivers intensive care quality ventilation to every patient, be it in intrahospital transport, in emergencies, or during air rescue operations. More...


The Dräger Oxylog 3000 plus is designed to support a wide range of patients and medical conditions and offers a range of volume control (VC) and pressure control (PC) based modes for controlled, synchronized, or spontaneous ventilation; when transporting critical care patients, the need of interrupting ventilation therapy is therefore eliminated. Flow and pressure curves are shown on a high-contrast electro-luminescence display that helps rescue personnel identify the parameters in critical ambient conditions, and maintain reliable patient monitoring. A new feature called AutoFlow (available in all VC modes) allows the patient to breathe spontaneously with the lowest pressure for breath volume, taking the individual lung mechanics into account. A patented blender permits a low oxygen concentration, which is continuously adjustable from 40 to 100%. Additionally, less sedation is required and alarms can be reduced.

The Oxylog 3000 recognizes insufficient spontaneous breathing and can automatically support the patient's breathing. In the event of an apnea in the continuous positive airway pressure (CPAP) mode, the Oxylog 3000 automatically initiates VC mandatory ventilation after a user defined apnea time. The Oxylog 3000 plus also comes with an integrated capnography function, which can be activated anytime by installing the sensor and software. The carbon dioxide (CO2) capnography feature allows the user to view the CO2 value and curve displays with no time delay, and as a result optimize the ventilation settings. Due to the utilized mainstream procedure, the ventilation system stays closed, and no sample gas needs to be routed into the device. The Dräger Oxylog 3000 plus was developed by Dräger Medical (Lübeck, Germany).

Related Links:

Dräger Medical






Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.